Savant Capital’s DexCom DXCM Stock Holding History

Savant Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Sell	15,175 -228	-1%	-$15.2K	﹤0.01%	876
2026 Q1	$967K	Buy	15,403 +1,053	+7%	+$73.3K	﹤0.01%	644
2025 Q4	$952K	Buy	14,350 +2,530	+21%	+$164K	0.01%	597
2025 Q3	$795K	Buy	+11,820	New	+$935K	﹤0.01%	639
2025 Q1	–	Sell	-110,383	Closed	-$8.58M	–	1184
2024 Q4	$8.58M	Buy	110,383 +9,731	+10%	+$720K	0.07%	173
2024 Q3	$6.75M	Sell	100,652 -234	-0.2%	-$19.2K	0.06%	185
2024 Q2	$11.4M	Sell	100,886 -3,941	-4%	-$498K	0.11%	125
2024 Q1	$14.5M	Sell	104,827 -2,293	-2%	-$288K	0.17%	102
2023 Q4	$13.3M	Sell	107,120 -3,941	-4%	-$403K	0.17%	100
2023 Q3	$10.4M	Sell	111,061 -831	-0.7%	-$93.7K	0.15%	110
2023 Q2	$14.4M	Sell	111,892 -1,290	-1%	-$156K	0.22%	83
2023 Q1	$13.1M	Sell	113,182 -5	-0%	-$560	0.24%	73
2022 Q4	$12.8M	Sell	113,187 -105	-0.1%	-$11.5K	0.31%	49
2022 Q3	$9.13M	Sell	113,292 -162	-0.1%	-$13.7K	0.28%	54
2022 Q2	$8.46M	Sell	113,454 -258	-0.2%	-$23.5K	0.26%	59
2022 Q1	$14.5M	Sell	113,712 -776	-0.7%	-$84.9K	0.48%	39
2021 Q4	$15.4M	Sell	114,488 -1,496	-1%	-$215K	0.5%	40
2021 Q3	$15.9M	Sell	115,984 -4,420	-4%	-$557K	0.58%	36
2021 Q2	$12.9M	Buy	120,404 +24	+0%	+$2.31K	0.52%	34
2021 Q1	$10.8M	Sell	120,380 -24	-0%	-$2.25K	0.58%	31
2020 Q4	$11.1M	Sell	120,404 -2,624	-2%	-$234K	0.65%	30
2020 Q3	$12.7M	Buy	123,028 +56	+0%	+$5.85K	0.87%	26
2020 Q2	$12.5M	Buy	122,972 +20	+0%	+$1.79K	0.94%	24
2020 Q1	$8.28M	Sell	122,952 -328	-0.3%	-$20.4K	0.79%	26
2019 Q4	$6.74M	Sell	123,280 -3,652	-3%	-$173K	0.83%	26
2019 Q3	$4.74M	Buy	126,932 +164	+0.1%	+$6.37K	0.66%	36
2019 Q2	$4.75M	Buy	126,768 +84	+0.1%	+$2.64K	0.67%	30
2019 Q1	$3.77M	Sell	126,684 -712	-0.6%	-$25K	0.71%	33
2018 Q4	$3.82M	Sell	127,396 -22,256	-15%	-$706K	0.8%	30
2018 Q3	$5.35M	Hold	149,652	–	–	0.96%	22
2018 Q2	$3.55M	Sell	149,652 -768	-0.5%	-$16.3K	0.76%	28
2018 Q1	$2.79M	Sell	150,420 -10,672	-7%	-$158K	0.59%	32
2017 Q4	$2.31M	Sell	161,092 -1,968	-1%	-$25.6K	0.49%	39
2017 Q3	$1.99M	Hold	163,060	–	–	0.45%	40
2017 Q2	$2.98M	Sell	163,060 -1,364	-0.8%	-$25.2K	0.7%	28
2017 Q1	$3.48M	Hold	164,424	–	–	0.86%	23
2016 Q4	$2.45M	Hold	164,424	–	–	0.66%	29
2016 Q3	$3.6M	Hold	164,424	–	–	0.99%	15
2016 Q2	$3.26M	Sell	164,424 -11,900	-7%	-$203K	0.93%	15
2016 Q1	$2.99M	Sell	176,324 -1,520	-0.9%	-$25.4K	0.91%	15
2015 Q4	$3.64M	Sell	177,844 -152	-0.1%	-$3.16K	1.14%	13
2015 Q3	$3.82M	Sell	177,996 -252	-0.1%	-$5.62K	1.37%	11
2015 Q2	$3.56M	Hold	178,248	–	–	1.2%	12
2015 Q1	$2.78M	Hold	178,248	–	–	0.98%	14
2014 Q4	$2.45M	Sell	178,248 -1,364	-0.8%	-$16.7K	0.93%	17
2014 Q3	$1.8M	Sell	179,612 -1,980	-1%	-$20.2K	0.76%	22
2014 Q2	$1.8M	Hold	181,592	–	–	0.78%	21
2014 Q1	$1.88M	Sell	181,592 -6,000	-3%	-$62K	0.87%	19
2013 Q4	$1.66M	Sell	187,592 -121,284	-39%	-$960K	0.81%	22
2013 Q3	$2.18M	Hold	308,876	–	–	1.19%	14
2013 Q2	$1.73M	Buy	+308,876	New	+$1.48M	1.01%	17

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Savant Capital's DXCM Position: Q2 2026 in Review

Savant Capital reduced its DexCom (DXCM) stake by 1.5% in Q2 2026, selling an estimated $15.2K and leaving 15,175 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Savant Capital first reported a position in DXCM in Q2 2013 and has held it in 51 quarters since. The position peaked at $15.9M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Savant Capital held 15,175 shares of DexCom worth $1.03M as of Q2 2026.
Savant Capital sold 228 DexCom shares in Q2 2026, an estimated $15.2K.
DexCom made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #876 holding.
Savant Capital first reported a position in DexCom in Q2 2013 and has held it in 51 quarters since.
Savant Capital's DexCom position peaked at $15.9M in Q3 2021.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.